Saved in:
| Main Authors: | Madeleine R. Heldman, Julia A. Messina, Annette J. Schlueter, Mark J. Lee, Jennifer L. Saullo, Rachel A. Miller |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1111/ctr.70073 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Cytomegalovirus (CMV) Serostatus Reassessment in CMV Seronegative Kidney Transplant Candidates
by: Ajmeet K. Pama‐Ghuman, et al.
Published: (2025)
by: Ajmeet K. Pama‐Ghuman, et al.
Published: (2025)
Debates in Management and Treatment of CMV in Pediatric Solid Organ Transplant Recipients: A Case‐Based Discussion
by: Kevin J. Downes, et al.
Published: (2025)
by: Kevin J. Downes, et al.
Published: (2025)
Utilization of a CMV T Cell Immunity Assay to Guide Secondary Prophylaxis in Solid Organ Transplant Recipients
by: Christina Doligalski, et al.
Published: (2026)
by: Christina Doligalski, et al.
Published: (2026)
Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance
by: Margaret R. Jorgenson, et al.
Published: (2024)
by: Margaret R. Jorgenson, et al.
Published: (2024)
What Would You Choose? Oral CMV Prophylaxis in Maintenance Hemodialysis Patients After Solid Organ Transplantation
by: Hidemasa Akazawa, et al.
Published: (2025)
by: Hidemasa Akazawa, et al.
Published: (2025)
Bridging the Gaps in CMV Management in Transplantation: Lessons From Resource‐Limited Settings
by: Carlos A. Gomez, et al.
Published: (2025)
by: Carlos A. Gomez, et al.
Published: (2025)
Clinically Significant EBV Infection in Allogeneic Stem Cell Transplanted Children Receiving Letermovir as Primary CMV Prophylaxis
by: Christina Oikonomopoulou, et al.
Published: (2025)
by: Christina Oikonomopoulou, et al.
Published: (2025)
Clinical and Economic Impact of CMV Infection in Allogeneic Hematopoietic Stem Cell Transplantation: Perspectives from a Middle‐Income Nation
by: Gin Gin Gan, et al.
Published: (2024)
by: Gin Gin Gan, et al.
Published: (2024)
Multidrug‐Resistant Gram‐Negative Urinary Tract Infections (UTIs) Increase the Risk of Rejection, CMV Viremia, and Graft Loss After Kidney Transplantation
by: Alessandra Palmisano, et al.
Published: (2026)
by: Alessandra Palmisano, et al.
Published: (2026)
Hepatitis B Virus NAT Positive Donors in Non‐Hepatic Organ Transplant: Quantifying Viral Loads to Optimize Recipient Risk Stratification and Management in the Prevention of Donor‐Derived Infection
by: Patrick C. K. Tam, et al.
Published: (2025)
by: Patrick C. K. Tam, et al.
Published: (2025)
Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept
by: Madeleine R. Heldman, et al.
Published: (2024)
by: Madeleine R. Heldman, et al.
Published: (2024)
CMV Reactivation Following Allogeneic Transplantation in Children From a High‐Seroprevalence Population: A Single‐Center Experience in Colombia
by: Andres Arias, et al.
Published: (2025)
by: Andres Arias, et al.
Published: (2025)
Congenital Cytomegalovirus (CMV)
Published: (2024)
Published: (2024)
Risk Factors and Outcomes of Recurrent Cytomegalovirus Infection in Heart Transplant Recipients
by: Vaisak O. Nair, et al.
Published: (2025)
by: Vaisak O. Nair, et al.
Published: (2025)
Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant
by: Suneri J. Amin, et al.
Published: (2025)
by: Suneri J. Amin, et al.
Published: (2025)
Pneumocystis jiroveci Pneumonia Infections in Pediatric Solid Organ Transplant Recipients
by: Emily A. Hayes, et al.
Published: (2025)
by: Emily A. Hayes, et al.
Published: (2025)
Infection Prevention and Surveillance in the Care of Australasian Solid‐Organ Transplant Recipients
by: Priya Garg, et al.
Published: (2025)
by: Priya Garg, et al.
Published: (2025)
Transmission of Ehrlichia chaffeensis From an Organ Donor to a Kidney–Pancreas Transplant Recipient
by: Praveen Gundelly, et al.
Published: (2025)
by: Praveen Gundelly, et al.
Published: (2025)
Updates on Vaccine‐Preventable Respiratory Viral Infections in Pediatric Solid Organ Transplant Recipients
by: Sanya J. Thomas, et al.
Published: (2025)
by: Sanya J. Thomas, et al.
Published: (2025)
Clinical Utility of Donor‐Derived Cell‐Free DNA in Heart Transplant Recipients With Multi‐Organ Transplants
by: Cathrine M. Moeller, et al.
Published: (2024)
by: Cathrine M. Moeller, et al.
Published: (2024)
Possible Donor‐Derived Tuberculosis in an Orthotopic Heart Transplant Recipient
by: Phani V. Akella, et al.
Published: (2026)
by: Phani V. Akella, et al.
Published: (2026)
An Update on Invasive Fungal Infections in Solid Organ Transplant Recipients
by: Tina Marinelli, et al.
Published: (2026)
by: Tina Marinelli, et al.
Published: (2026)
International Survey on Antibiotic Prophylaxis Approaches for Solid Organ Transplant Recipients and Donors Colonized With Multidrug‐Resistant Organisms
by: Julia Bini Viotti, et al.
Published: (2025)
by: Julia Bini Viotti, et al.
Published: (2025)
Risk of Cytomegalovirus Viremia Following Transplantation of Hepatitis C‐Viremic Donor Kidneys Into Uninfected Recipients: A Multi‐Center Retrospective Cohort Study
by: Vishnu S. Potluri, et al.
Published: (2025)
by: Vishnu S. Potluri, et al.
Published: (2025)
Donor‐Derived Strongyloides Infection Leading to Hyperinfection Syndrome in a Heart Transplant Recipient
by: Ana Khazan, et al.
Published: (2026)
by: Ana Khazan, et al.
Published: (2026)
Survival Outcomes of Liver Transplantation Amid Rising Recipient and Donor Risk Profiles
by: Eishan Ashwat, et al.
Published: (2025)
by: Eishan Ashwat, et al.
Published: (2025)
Resistant/Refractory Cytomegalovirus Retinitis in Solid Organ and Hematopoietic Stem Cell Transplant Recipients: The Cause‐or‐Consequence Dilemma
by: Renato Pascale, et al.
Published: (2026)
by: Renato Pascale, et al.
Published: (2026)
Evaluation of the VIDAS Cytomegalovirus (CMV)‐IGRA for Assessing CMV‐Specific T‐Cell Responses in Immunocompetent and Immunosuppressed Individuals
by: Estela Giménez, et al.
Published: (2025)
by: Estela Giménez, et al.
Published: (2025)
A Scoping Review of Arthropod‐Borne Flavivirus Infections in Solid Organ Transplant Recipients
by: Seohyeon Im, et al.
Published: (2024)
by: Seohyeon Im, et al.
Published: (2024)
Dosing, Safety, and Tolerability of Extended‐Release Tacrolimus in Pediatric and Young Adult Solid Organ Transplant Recipients
by: Terry Dang, et al.
Published: (2026)
by: Terry Dang, et al.
Published: (2026)
Impact of Donor and Recipient Sex on Long‐Term Outcomes Following Living Donor Kidney Transplantation: A Retrospective Dual‐Center Study
by: Yitian Fang, et al.
Published: (2025)
by: Yitian Fang, et al.
Published: (2025)
Bacteremia in Pediatric Solid Organ Transplant Recipients within 1 Year of Transplant
by: Mario M. Landa, et al.
Published: (2025)
by: Mario M. Landa, et al.
Published: (2025)
The Impact of Epstein–Barr Virus Serostatus Mismatch in Adult Kidney Transplant Recipients: An Analysis of the 2012–2022 OPTN Database
by: Namrata Parikh, et al.
Published: (2025)
by: Namrata Parikh, et al.
Published: (2025)
Living Donor Intestinal Transplant: Indication, Techniques, Surgical Complications, and Outcomes in Recipients and Donors: A Systematic Review
by: Adil Nusair, et al.
Published: (2026)
by: Adil Nusair, et al.
Published: (2026)
De Novo Letermovir for Cytomegalovirus Prophylaxis in High‐Risk Liver Transplant Recipients
by: Hanna L. Kleiboeker, et al.
Published: (2025)
by: Hanna L. Kleiboeker, et al.
Published: (2025)
Suitability of Infant Heart Transplant Recipients to Serve as Domino Partial Heart Transplant Donors
by: Meagan O. Rogers, et al.
Published: (2024)
by: Meagan O. Rogers, et al.
Published: (2024)
Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancy
by: Patrick C. K. Tam, et al.
Published: (2026)
by: Patrick C. K. Tam, et al.
Published: (2026)
Impact of Donor CMV‐Seropostive Grafts on Prognosis of Liver Transplantation for Hepatocellular Carcinoma
by: Ze Xiang, et al.
Published: (2025)
by: Ze Xiang, et al.
Published: (2025)
Venous Thromboembolism in Brain‐Dead Organ Donors: A Prospective Study of Prevalence, Management, and Impact on Organ Utilization and Recipient Outcomes
by: Hailey M. Shepherd, et al.
Published: (2025)
by: Hailey M. Shepherd, et al.
Published: (2025)
Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
by: Abdallah Mughrabi, et al.
Published: (2026)
by: Abdallah Mughrabi, et al.
Published: (2026)
Similar Items
-
Cytomegalovirus (CMV) Serostatus Reassessment in CMV Seronegative Kidney Transplant Candidates
by: Ajmeet K. Pama‐Ghuman, et al.
Published: (2025) -
Debates in Management and Treatment of CMV in Pediatric Solid Organ Transplant Recipients: A Case‐Based Discussion
by: Kevin J. Downes, et al.
Published: (2025) -
Utilization of a CMV T Cell Immunity Assay to Guide Secondary Prophylaxis in Solid Organ Transplant Recipients
by: Christina Doligalski, et al.
Published: (2026) -
Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance
by: Margaret R. Jorgenson, et al.
Published: (2024) -
What Would You Choose? Oral CMV Prophylaxis in Maintenance Hemodialysis Patients After Solid Organ Transplantation
by: Hidemasa Akazawa, et al.
Published: (2025)